Protagenic Therapeutics, Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 6/26/2017
Contact Info
  • 149 Fifth Ave
  • Suite 500
  • New York, NY 10010

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Deregistered a/o Mar 30, 2012
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0001022899
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 7389 - Business services, misc
Incorporated In: DE, USA
Year of Inc. 1994
Employees 3 a/o Mar 31, 2017
Company Officers/Contacts
Alexander K. Arrow CFO
Carol Haggerty Administrator
Company Directors
Garo H. Armen Executive Chairman
Brian Corvese Director, Audits
Khalil Barrage
Josh Silverman
Robert B. Stein
Company Notes
  • Formerly=Atrinsic, Inc. until 7-2016
  • Formerly=New Motion, Inc. until 6-2009
  • Formerly=MPLC, Inc. until 5-07
  • Formerly=MPLC, Inc. (formerly Millbrook Press Inc. (The)) until 8-06
  • Note=12-5-05 final bankruptcy distribution made to eligible shareholders & company continues to trade as a shell
  • Note=10-20-05 company is a shell, intending to acquire assets or shares of an entitiy in a business that generates revenues
  • Note=2-6-04 company filed petition under Chapter XI of the Federal Bankruptcy Code in the U.S. Bankruptcy Court for the District of Connecticut
Service Providers
Accounting/Auditing Firm
MaloneBailey, LLP
9801 Westheimer Road
Suite 1100
Houston, TX, 77042
United States

Legal Counsel
Meister Seelig & Fein LLP
125 Park Avenue
7th Floor
New York, NY, 10017
United States

Investor Relations Firm
Not Available
PTIX Security Details
Share Structure
Market Value1 $17,957,483 a/o Oct 19, 2017
Authorized Shares 100,000,000 a/o Dec 31, 2016
Outstanding Shares 10,261,419 a/o May 27, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 6,206,905 a/o Jun 23, 2017
Par Value 0.01
Shareholders of Record 434 a/o Apr 18, 2017
Short Selling Data
Short Interest 1 (0%)
Sep 29, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security